News
GSK joins Flagship's flotilla of pharma partners
Flagship Pioneering has signed yet another strategic-level deal with …
19702 items found
News
NewAmsterdam obicetrapib data disappoints some investors
Shares in NewAmsterdam Pharma were sliding today after it reported a …
News
NICE blocks Enhertu use after pricing talks break down
NICE and drugmakers AstraZeneca and Daiichi Sankyo have all expressed …
News
UK partnership aims to support NHS use of depression app
Otsuka has teamed up with one of the innovation arms of the NHS to …
Digital
The imperative of agility in UK healthcare cybersecurity
In an era where cyber threats are becoming increasingly …
News
AMPLIFY results dial up Calquence's potential in CLL
AstraZeneca's Calquence has hit the mark in the phase 3 AMPLIFY trial …
News
Ipsen's Alagille drug backed by CHMP again, with new name
In unusual circumstances, Ipsen has been given the green light for …
R&D
Sponsored
Biologics contract manufacturing: A comprehensive guide for pharmaceutical companies
The pharmaceutical industry is undergoing a profound transformation, …
News
LEO closes on first approval for chronic hand eczema drug
Danish dermatology specialist LEO Pharma could be just weeks away …
News
In shock move, EU panel rejects Alzheimer's drug Leqembi
The EMA's human medicines committee has recommended against approval …
R&D
Health Innovators - Steve Damon
The hypodermic needle was invented in 1844 by Francis Rynd and, while …
News
Third Arc's $165m for T cell engagers, plus other bio rounds
This week's round-up of new financings in the biotech world is headed …
News
Seaport docks $225m for its improved neuropsychiatry drugs
After emerging from the shadows with a $100 million Series A in April, Seaport Therapeutics has moved swiftly to shore up its finances with a $225 million second round to fund the developme
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
